Highest Plasma Phenylalanine Levels in (Very) Premature Infants on Intravenous Feeding; A Need for Concern

Ernesto Cortés-Castell1, Pablo Sánchez-González2, Antonio Palazón-Bru3

  • 1Department of Pharmacology, Paediatrics and Organic Chemistry, Miguel Hernández University, San Juan de Alicante, Spain.

Plos One
|September 22, 2015
PubMed

Insights

Newborn blood phenylalanine levels are higher in premature infants and those on intravenous feeding. Careful monitoring and tailored nutrition are crucial for these vulnerable newborns.

Area of Science:

  • Neonatal Medicine
  • Biochemistry
  • Pediatrics

Background:

  • Blood phenylalanine levels are a key indicator in newborn screening.
  • Gestational age and feeding methods can influence neonatal metabolic profiles.

Purpose of the Study:

  • To investigate the relationship between blood phenylalanine levels and feeding methods in newborns.
  • To examine the association between phenylalanine levels and gestational age in neonates.

Main Methods:

  • An observational, cross-sectional study of 11,829 infants (2008-2013) in Spain.
  • Data collected on phenylalanine values, feeding method (breast, formula, mixed, intravenous), and gestational age.
  • Multivariate linear and logistic regression models were used for analysis.

Main Results:

  • Higher phenylalanine concentrations were significantly associated with lower gestational age (p<0.001).
  • Intravenous feeding was also strongly correlated with elevated phenylalanine levels (p<0.001).

Conclusions:

  • Prematurity and intravenous nutrition significantly impact newborn plasma phenylalanine concentrations.
  • Close monitoring of phenylalanine levels is recommended for infants receiving intravenous feeding.
  • Adjusting nutrient intake based on individual infant needs is essential, particularly for very preterm infants.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
474
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
335
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
745
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.6K